ADHD medicine Zenzedi recalled — contains drug with opposite effect

medicine

by Adriana Diaz

A popular treatment for attention-deficit hyperactivity disorder (ADHD) has been recalled after another drug was found in the packaging.

Azurity Pharmaceuticals has recalled 30 milligram dextroamphetamine sulfate tablets sold under the brand name Zenzedi.

The move comes after a pharmacist in Nebraska opened a bottle and found carbinoxamine maleate tablets, an antihistamine, mixed in with ADHD medication. The Food and Drug Administration warned.

The recalled product (part of lot number F230169A) expires in June 2025 and was recalled on January 4th.

The two drugs have opposite effects.

Dextroamphetamine sulfate is a stimulant, while carbinoxamine maleate, an antihistamine used to treat allergies, has sedative effects.

“Patients who take carbinoxamine instead of Zenzedi may have inadequately treated symptoms, which may result in functional impairment and increased risk of accidents and injuries,” the FDA explained.

People who unknowingly take carbinoxamine may experience adverse events including, but not limited to, drowsiness, drowsiness, central nervous system (CNS) depression, increased intraocular pressure, enlarged prostate, urinary tract obstruction, and thyroid disorders. There is.”

People who have been diagnosed with ADHD or narcolepsy may suffer from “ongoing disability or injury” caused by accidental ingestion of carbinoxamine while participating in activities that require concentration and alertness, such as driving or operating heavy machinery. There is a “substantial probability” that it could lead to death. .

Zenzedi 30 milligram tablets are pale yellow hexagonal tablets with “30” written on one side and “MIA” written on the other side. ADHD medications must be distributed in white bottles with black writing and “30 mg” highlighted in yellow.

Carbinoxamine Maleate 4-milligram tablets, on the other hand, are white, round tablets with “GL” stamped on one side and “211” on the other.

Patients with recalled products are advised to stop using them and return to the place of purchase.

This news is particularly concerning as the country continues to run into shortages of common ADHD medications such as Adderall.